UPDATE : Friday, July 10, 2020
상단여백
‘Keytruda alone works as first-line therapy for lung cancer’
MSD’s immunotherapy Keytruda (ingredient: pembrolizumab) should be a standa...
by Kim Yun-mi  |  2020-04-29 11:40
라인
‘Pexa-Vec with immunotherapy reduced tumor in 75% of kidney cancer patients’
SillaJen said a combination of its oncolytic viral therapy Pexa-Vec (JX-594...
by Jeong Sae-im  |  2020-04-28 17:35
라인
Genexine’s cervical cancer DNA vaccine boosts Keytruda’s response rate
Genexine said its investigational DNA vaccine for cervical cancer has impro...
by Jeong Sae-im  |  2020-04-28 14:48
라인
Researchers start testing pancreatitis drug to fight Covid-19
The Ministry of Food and Drug Safety has approved a local investigator-init...
by Kim Yun-mi  |  2020-04-28 11:22
라인
Genexine to present test results at US cancer academy
Genexine will release the interim results of its clinical trials on the com...
by Shim Hyun-tai  |  2020-04-27 16:14
라인
‘Parasiticide showed antiviral effect as potential Covid-19 drug’
“Niclosamide showed an antiviral effect, regulating the autophagy function ...
by Jeong Sae-im  |  2020-04-24 12:27
라인
French envoy visits Pasteur Korea to watch Covid-19 research
French Ambassador Philippe Lefort visited Institut Pasteur Korea (IPK) in P...
by Jeong Sae-im  |  2020-04-23 17:13
라인
Multinational drugmakers donated ₩30 billion last year
Twenty-eight multinational pharmaceutical companies operating in Korea dona...
by Kim Yun-mi  |  2020-04-23 15:09
라인
4 drugs recorded two-digit sales growth in Q1 despite Covid-19
The new coronavirus slowed the growth of the overall outpatient drug prescr...
by Jeong Sae-im  |  2020-04-23 12:18
라인
Medytox’s faking data unpunishable due to expired statute of limitations
Prosecutors have reportedly found that Medytox fabricated data to win appro...
by Jeong Sae-im  |  2020-04-22 11:28
라인
Abclon derives clinical materials for CAR-T treatment of ovarian cancer
Antibody-based therapeutics developer Abclon said Tuesday that it has succe...
by Shim Hyun-tai  |  2020-04-21 17:49
라인
Multidisciplinary cure is mainstream cancer treatment but cumbersome
“Cancer” is the area where multidisciplinary treatments are being made most...
by Park Gi-taek  |  2020-04-21 17:09
라인
Whistleblowers, shareholders furious over Medytox’s rebuttal
The whistleblowers who revealed Medytox’s alleged illegal manufacturing of ...
by Jeong Sae-im  |  2020-04-21 15:19
라인
ImmuneMed confident of drug candidate’s effect on Covid-19
ImmuneMed said its inflammatory viral disease treatment HzVSF (humanized vi...
by Jeong Sae-im  |  2020-04-21 13:23
라인
Medytox files suit to cancel administrative order
Medytox has filed a lawsuit against the Ministry of Food and Drug Safety to...
by Shim Hyun-tai  |  2020-04-20 16:37
라인
DM Bio signs CDMO contract with Abion for antibody treatment
DM Bio said it has signed a CDMO (contract development and manufacturing or...
by Shim Hyun-tai  |  2020-04-17 16:03
라인
Medytox CEO charged with making, selling botulinum toxin illegally
Prosecutors said Friday they have indicted Medytox CEO Jung Hyun-ho on char...
by Jeong Sae-im  |  2020-04-17 16:00
라인
Researchers to test asthma drug to treat Covid-19
Local infectious disease specialists said they would evaluate the potential...
by Kim Yun-mi  |  2020-04-16 16:20
라인
Bukwang to test its antiviral drug against Covid-19
Bukwang Pharm said its hepatitis B treatment Levovir (ingredient: clevudine...
by Jeong Sae-im  |  2020-04-16 12:20
라인
Opdivo’s indication expanded to esophageal squamous cell carcinoma
A new treatment option has become available in the local esophageal cancer ...
by Kim Yun-mi  |  2020-04-16 10:48
여백
여백
여백
Back to Top